| Composition | Rosuvastatin 20mg Aspirin 75mg Clopidogrel 75mg |
|---|---|
| Dosage | CAPSULE |
| Packing Size | 10×10 |
| Packing | Alu-Alu |
ROZVIN GOLD 20 is a triple-combination cardiovascular therapy designed for patients at risk of heart attack, stroke, and atherosclerosis. It combines Rosuvastatin (20 mg) for cholesterol management, Aspirin (75 mg) for antiplatelet action, and Clopidogrel (75 mg) for enhanced platelet inhibition.
This unique formulation helps in reducing cardiovascular events, controlling lipid levels, and preventing blood clots, providing comprehensive heart protection in a single tablet.
Each tablet contains:
Rosuvastatin 20 mg – A statin that lowers LDL cholesterol, total cholesterol, and triglycerides while increasing HDL cholesterol, reducing atherosclerotic risk.
Aspirin 75 mg – An antiplatelet agent that prevents platelet aggregation, reducing the risk of heart attack and stroke.
Clopidogrel 75 mg – A P2Y12 platelet inhibitor that prevents thrombus formation and enhances cardiovascular protection.
(Excipients q.s., as per approved formulation.)
Tablet
Cardiovascular Protection / Lipid-Lowering & Antiplatelet Therapy
ROZVIN GOLD 20 is indicated for:
Patients with high cholesterol or mixed dyslipidemia
Prevention of heart attack, stroke, or cardiovascular events in high-risk patients
Secondary prevention in patients with previous myocardial infarction or coronary artery disease
Patients requiring dual antiplatelet therapy combined with cholesterol control
Rosuvastatin reduces cholesterol synthesis in the liver, stabilizes atherosclerotic plaques, and lowers cardiovascular risk.
Aspirin irreversibly inhibits platelet aggregation, preventing blood clot formation.
Clopidogrel blocks P2Y12 receptors on platelets, preventing aggregation and reducing the risk of thrombotic events.
The combination provides comprehensive cardiovascular protection by targeting both lipid management and antiplatelet therapy.
Recommended Dose: As prescribed by the physician, usually once daily.
Route: Oral
Duration: Long-term therapy as advised by a healthcare provider
Note: Regular monitoring of lipid profile, platelet function, and liver function is recommended during therapy.
Controls high cholesterol and triglycerides
Prevents platelet aggregation and thrombus formation
Reduces the risk of heart attack, stroke, and atherosclerosis
Provides dual antiplatelet protection with lipid-lowering benefits
Convenient once-daily tablet enhances patient compliance
ROZVIN GOLD 20 is generally well tolerated. Possible side effects include:
Mild gastrointestinal discomfort
Headache or dizziness
Muscle pain or weakness (associated with statins)
Increased bleeding risk (due to antiplatelet agents)
Patients should consult their physician if side effects persist or worsen.
Avoid in patients with active bleeding disorders or history of hemorrhagic stroke
Use with caution in liver or kidney impairment
Not recommended during pregnancy or lactation
Inform your doctor about other medications to prevent interactions
Regular blood tests are advised to monitor liver enzymes and platelet function
Store below 25°C, in a dry place away from light and moisture. Keep out of reach of children.
Brand Name: ROZVIN GOLD 20
Composition: Rosuvastatin 20 mg + Aspirin 75 mg + Clopidogrel 75 mg
Dosage Form: Tablet
Therapeutic Class: Cardiovascular Protection / Lipid-Lowering & Antiplatelet
Manufacturer: [Insert Company Name]
Packaging: [Example: 10×10 Tablets / Strip]
Combines cholesterol management and dual antiplatelet therapy in a single tablet
Helps reduce cardiovascular risk in high-risk patients
Convenient once-daily dosing improves adherence
Manufactured under GMP-certified quality standards
ROZVIN GOLD 20 (Rosuvastatin 20 mg + Aspirin 75 mg + Clopidogrel 75 mg) is a comprehensive cardiovascular protective therapy. By combining lipid-lowering action with dual antiplatelet effects, it helps prevent heart attacks, strokes, and thrombotic events, providing effective, long-term heart protection for patients at risk.
